WuXi PharmaTech Cayman Inc. (WX:US) rose 14 percent to $12.02 after jumping earlier to $12.30, the highest intraday price since October 2008. The Chinese contract researcher for drugmakers reported 72 percent more per-share profit than analysts estimated for the second quarter.